Cargando…

Editorial: Time to explore the missing links: from activated platelets and platelet extracellular vesicles in SARS-CoV-2 infection, through heterogeneity in the host physiological, immuno-inflammatory and haemostatic responses to mRNA-based vaccine or infection induced polyclonal neutralizing antibodies and passive immunity

Detalles Bibliográficos
Autor principal:	Seghatchian, Jerard
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Published by Elsevier Ltd. 2022
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9122738/ https://www.ncbi.nlm.nih.gov/pubmed/35623956 http://dx.doi.org/10.1016/j.transci.2022.103464

Ejemplares similares

Platelet and extracellular vesicles in COVID-19 infection and its vaccines
por: Goubran, Hadi, et al.
Publicado: (2022)

Updates on Stem Cell Therapy in Transfusion Medicine, New Approaches to RBC Substitution Therapy, the Use of IFC for the Assessment of Extracellular- Derived Vesicles/Exosomes
por: Seghatchian, Jerard
Publicado: (2020)

On the Quest for In Vitro Platelet Production by Re-Tailoring the Concepts of Megakaryocyte Differentiation
por: Martínez-Botía, Patricia, et al.
Publicado: (2020)

Editorial: Time to explore the missing links: the cross-talk between COVID infection and cancer cells; lingering questions on the longitudinal efficacy of the front line immunotherapies against unpredictable “Omicron ghosts” and insights from CAR-T cell therapy pointing toward better clinical outcomes
por: Seghatchian, Jerard
Publicado: (2022)

Platelets: Still a Therapeutical Target for Haemostatic Disorders
por: Geraldo, Reinaldo Barros, et al.
Publicado: (2014)

Haemostatic parameters, platelet activation markers, and platelet indices among regular plateletpheresis donors
por: Tuan, Hulwani T.M., et al.
Publicado: (2017)

Spotlight on SARS CoV-2 infection inducing autoimmunity, through the formation of autoantibody to self hemostatic components or to host cells, often leading to severe thrombotic or bleeding events
por: Seghatchian, Jerard
Publicado: (2023)

An update on COVID-19 infection control measures, plasma-based therapeutics, corticosteroid pharmacotherapy and vaccine research
por: Putter, Jeffrey S., et al.
Publicado: (2020)

T-cell lymphocytopenia: An omnipresent predictor of morbidity and mortality in consequence of SARS-CoV disease and influenza A infections
por: Putter, Jeffrey S., et al.
Publicado: (2023)

The Non-Haemostatic Response of Platelets to Stress: An Actor of the Inflammatory Environment on Regenerative Medicine?
por: Cognasse, Fabrice, et al.
Publicado: (2021)

Platelets and Platelet‐Derived Extracellular Vesicles in Liver Physiology and Disease
por: Balaphas, Alexandre, et al.
Publicado: (2019)

Implication of Platelets in Immuno-Thrombosis and Thrombo-Inflammation
por: Zaid, Younes, et al.
Publicado: (2022)

Update on newer approaches to prevent or treat COVID-19 infection: What we all need the most right now!!
por: Seghatchian, Jerard, et al.
Publicado: (2020)

The secrets of human stem cell-derived transfusable RBC for targeted large-scale production and clinical applications: A fresh look into what we need most and lessons to be learned
por: Seghatchian, Jerard
Publicado: (2020)

In vitro mass production of reproducible human cells destined for substitution therapy: Challenges for development of functional materials for what we need most in transfusion!
por: Seghatchian, Jerard
Publicado: (2020)

Facts and challenges on global deployment of vaccines for the immunotherapy of the evolving SARS Cov-2 variants: What a new year, with a fast spreading South African and the most fearful Brazilian variants, as the unwanted gifts, imposing enormous crises to surmount
por: Seghatchian, Jerard
Publicado: (2021)

New generation of vaccines and convalescent plasma therapy for management of CoV-2: Perspectives from the UK and potential deployment in the current global pandemic
por: Seghatchian, Jerard
Publicado: (2021)

Do highly transmissible omicron subtypes BA.4/BA.5 have any impact on the HLA class I /II antibodies of apheresis donors, and could mucosal omicron-specific vaccines prevent transmissibility and provide more durable protection?
por: Seghatchian, Jerard
Publicado: (2022)

Passive Monoclonal and Polyclonal Antibody Therapies
por: Pelletier, J. Peter R., et al.
Publicado: (2020)

Characterization of procoagulant extracellular vesicles and platelet membrane disintegration in DMSO-cryopreserved platelets
por: Tegegn, Tseday Z., et al.
Publicado: (2016)

Contributing role of extracellular vesicles on vascular endothelium haemostatic balance in cancer
por: Bouvy, Céline, et al.
Publicado: (2014)

Dynamics of Platelet Counts in Major Trauma: The Impact of Haemostatic Resuscitation and Effects of Platelet Transfusion—A Sub-Study of the Randomized Controlled RETIC Trial
por: Tauber, Helmuth, et al.
Publicado: (2020)

Circulating Platelet-Derived Extracellular Vesicles Are a Hallmark of Sars-Cov-2 Infection
por: Cappellano, Giuseppe, et al.
Publicado: (2021)

Isolation and characterization of platelet-derived extracellular vesicles
por: Aatonen, Maria T., et al.
Publicado: (2014)

Understanding the biosynthesis of platelets-derived extracellular vesicles
por: Antwi-Baffour, Samuel, et al.
Publicado: (2015)

Platelet-Derived Extracellular Vesicles for Regenerative Medicine
por: Antich-Rosselló, Miquel, et al.
Publicado: (2021)

Therapeutic Use of Convalescent Plasma in COVID-19 Infected Patients with Concomitant Hematological Disorders
por: Lanza, Francesco, et al.
Publicado: (2021)

Platelets and Infection – An Emerging Role of Platelets in Viral Infection
por: Assinger, Alice
Publicado: (2014)

Activated Platelets and Platelet-Derived Extracellular Vesicles Mediate COVID-19-Associated Immunothrombosis
por: Ebeyer-Masotta, Marie, et al.
Publicado: (2022)

Lack of Protection following Passive Transfer of Polyclonal Highly Functional Low-Dose Non-Neutralizing Antibodies
por: Dugast, Anne-Sophie, et al.
Publicado: (2014)

Trends and targets of various types of stem cell derived transfusable RBC substitution therapy: Obstacles that need to be converted to opportunity
por: Lanza, Francesco, et al.
Publicado: (2020)

“Go no Go” in plasma fractionation in the world's emerging economies: Still a question asked 70 years after the COHN process was developed!
por: Burnouf, Thierry, et al.
Publicado: (2014)

Ebola virus convalescent blood products: Where we are now and where we may need to go
por: Burnouf, Thierry, et al.
Publicado: (2014)

Autoimmune complications of COVID-19 and potential consequences for long-lasting disease syndromes
por: Amiral, Jean, et al.
Publicado: (2023)

Biology of Platelet Purinergic Receptors and Implications for Platelet Heterogeneity
por: Koupenova, Milka, et al.
Publicado: (2018)

Expanding applications of allogeneic platelets, platelet lysates, and platelet extracellular vesicles in cell therapy, regenerative medicine, and targeted drug delivery
por: Burnouf, Thierry, et al.
Publicado: (2023)

Emerging roles of platelet concentrates and platelet-derived extracellular vesicles in regenerative periodontology and implant dentistry
por: Sun, Jiayue, et al.
Publicado: (2022)

Platelet-derived Extracellular Vesicles: An Emerging Therapeutic Approach
por: Tao, Shi-Cong, et al.
Publicado: (2017)

Platelets, extracellular vesicles and coagulation in pulmonary arterial hypertension
por: Cullivan, Sarah, et al.
Publicado: (2021)

Platelet-released extracellular vesicles: the effects of thrombin activation
por: Suades, Rosa, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_llhsdl0tfkeo5ejlnucfde3rkr